Evidence map›Paper›PMID 30421030›Full record

ReviewImmunogenetics2019

Class II MHC antigen processing in immune tolerance and inflammation.

Mollie M Jurewicz, Lawrence J Stern

Registry-linked trialAbstract readReview
In one paragraph

Review in Immunogenetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04846010 (Treating Sequalae Caused by Post-acute Sequelae of SARS), which is not on this map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04846010 phase1 / phase2unknown statusnot on this mapstarted 2021, after this paper: background citation

Treating Sequalae Caused by Post-acute Sequelae of SARS (Severe Acute Respiratory Syndrome)-CoV-2 Infection

TypeinterventionalSponsorAll Natural Medicine Clinic, LLCRan2021 to 2022Enrolled2,000ConditionsSequelae of, Infection, Post Infection Glomerulonephritis, Post-Infectious Peripheral NeuralgiaArmsPurWet, FurFat, PurApo, PurPhl, PurClo
3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Dietary Encapsulation of a NovelAntioxidants (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Peptides Derived from α-Tubulin Induce Functional T Regulatory Cells.International journal of molecular sciences · 2025
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mollie M JurewiczImmunology and Microbiology Graduate Program and Department of Pathology, University of Massachusetts Medical School, Worcester, MA, 01655, USA.
Lawrence J SternImmunology and Microbiology Graduate Program and Department of Pathology, University of Massachusetts Medical School, Worcester, MA, 01655, USA. lawrence.stern@umassmed.edu.

Funding

TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
HLA-DO / H2-O: modulation of MHC-II peptide diversity and Treg population controlR01AI127869 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 2018 to 2022
$2.7M
NIAID NIH HHS R01 AI127869NIAID NIH HHS T32 AI007349
6 · The paper itself

Abstract

Presentation of peptide antigens by MHC-II proteins is prerequisite to effective CD4 T cell tolerance to self and to recognition of foreign antigens. Antigen uptake and processing pathways as well as expression of the peptide exchange factors HLA-DM and HLA-DO differ among the various professional and non-professional antigen-presenting cells and are modulated by cell developmental state and activation. Recent studies have highlighted the importance of these cell-specific factors in controlling the source and breadth of peptides presented by MHC-II under different conditions. During inflammation, increased presentation of selected self-peptides has implications for maintenance of peripheral tolerance and autoimmunity.

Indexed as

AnimalsAntigen PresentationAntigen-Presenting CellsHistocompatibility Antigens Class IIHumansImmune ToleranceInflammationT-LymphocytesHistocompatibility Antigens Class IIAntigen presentationImmunopeptidomeMajor histocompatibility complexMHC protein

Identifiers

PMID30421030
PMCPMC6377339

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.